Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Various and different peptides products resulting from enzymatic protein cleavage of Amyloid Precursor Proteins (APP) are the main agents in the pathophysiology of Alzheimer’s disease (AD). Although relatively well-known, they still arouse interest leading to further intense and wide-ranging research. Their biology and physico-chemical properties still are challenging for basic, experimental research and are matter of scientific debate. The APP itself and its functions are still somewhat enigmatic and therefore it is also called the All Purpose Protein. Apart from well known amyloidogenic and antiamyloidogenic (non-amyloidogenic) enzymatic cleavage pathways of APP protein this paper deals with issues connected with other, alternative pathways that seem to be interesting and important as well. They lead to other than Aβ forms of peptide products such as: N-APP, N-terminally cleavage products of APP (N-terminally truncated ) Aβ’, γ- secretase-independent pathway products that involve concerted cleavages of APP by α- and β-secretase or products that emerge after caspase activity. Presence of all these peptides in CSF, ISF, blood serum and urine of the AD patients is crucial for successful diagnosis, giving rise to hope of their better detection and potentially better treatment of AD. Therefore, newly discovered products of the AβT domain cleavage (Aβ total i.e. full fibrillating domain of APP), Aβ type products and other peptides because of their biology and physico-chemical properties are very intriguing and deserve further experimental research. On the other hand after better recognition and better understanding their biology they might be enormously useful in the future for diagnosis and therapy for example Alzheimer’s disease.

Authors and Affiliations

Małgorzata Marszałek

Keywords

Related Articles

The role of genetic (PON1 polymorphism) and environmental factors, especially physical activity, in antioxidant function of paraoxonase*

Paraoxonase 1 ([i]PON1[/i]) is a member of a three-gene family ([i]PON1, PON2[/i], and [i]PON3[/i]). PON1 activity dominates in human plasma. It is secreted from hepatic cells and is found in the circulation bound to hig...

Białka w oporności wielolekowej nowotworów

Wielolekooporność definiowana jest jako brak wrażliwości na podawane leki, które nie wykazują strukturalnego podobieństwa, a ponadto mają zróżnicowane molekularne punkty uchwytu. Nowotwory dysponują licznymi mechanizmami...

Biologiczne znaczenie oksydacyjnych modyfikacji reszt cysteinowych w białkach na przykładzie dehydrogenazy aldehydu 3-fosfoglicerynowego

Dehydrogenaza aldehydu 3-fosfoglicerynowego (GAPDH) jest białkiem szczególnie podatnym na oksydacyjne modyfikacje. Na aktywność tego enzymu w dużym stopniu wpływają modyfikacje reaktywnej reszty cysteinowej występującej...

Diagnostyka uszkodzeń i dysfunkcji mięśnia sercowego wywołanych antracyklinami

Standardowym postępowaniem w trakcie chemioterapii z użyciem antracyklin jest ocena czynności serca przed rozpoczęciem leczenia, monitorowanie potencjalnego działania kardiotoksycznego w trakcie chemioterapii, a także po...

The role of disorders of the prooxidant-antioxidant system in diabetes etiopathology

Chronic hyperglycemia is believed to play a pivotal role in the development of diabetic complications. It was found that hyperglycemia triggered a number of mechanisms that evoke overproduction of reactive oxygen species...

Download PDF file
  • EP ID EP220823
  • DOI -
  • Views 123
  • Downloads 0

How To Cite

Małgorzata Marszałek (2016). Alzheimer’s disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides – some aspects. Advances in Hygiene and Experimental Medicine, 70(), 787-796. https://europub.co.uk/articles/-A-220823